Different Effects of Thiazolidinediones on In-Stent Restenosis and Target Lesion Revascularization after PCI: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Different Effects of Thiazolidinediones on In-Stent Restenosis and Target Lesion Revascularization after PCI: A Meta-Analysis of Randomized Controlled Trials

Published:2017-10-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhou Xinbin,Chen Shenjie,Zhu Min,Hua Junyi,Dai Jin,Xu Xiaoming,Qiu Yuangang,Mao Wei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14873-0.pdf

Reference46 articles.

1. Dangas, G. D. et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56, 1897–907 (2010).

2. Roiron, C., Sanchez, P., Bouzamondo, A., Lechat, P. & Montalescot, G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92, 641–9 (2006).

3. Yasmin, S. & Jayaprakash, V. Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present. Eur J Med Chem 126, 879–893 (2017).

4. Joner, M. et al. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1. Arterioscler Thromb Vasc Biol 27, 182–9 (2007).

5. Kasai, T. et al. Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting. Atherosclerosis 197, 612–9 (2008).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review;Cells;2024-09-05

2. STATINS AND THE RISK FOR CORONARY IN-STENT RESTENOSIS IN DIABETIC PATIENTS;FARMACIA;2021-06-28

3. Efficacy and Cardiovascular Safety of Thiazolidinediones;Current Drug Safety;2021-06-08

4. Targeting smooth muscle cell phenotypic switching in vascular disease;JVS: Vascular Science;2021

5. Aim to normalize glucose levels and reduce cardiovascular mortality when managing type 2 diabetes in the elderly;Drugs & Therapy Perspectives;2019-03-13